OptiNose (OPTN) Tops Q3 EPS by 1c

OptiNose (NASDAQ: OPTN) reported Q3 EPS of ($0.18), $0.01 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $20.1 million versus the consensus estimate of $23.55 million.

GUIDANCE:

OptiNose sees Q4 2022 revenue of $74-78 million.

For earnings history and earnings-related data on OptiNose (OPTN) click here.

You May Also Be Interested In

• Citi cuts Micron stock target, sees memory chip prices peaking in 2Q27
• Revelation Biosciences (REVB) Misses Q2 EPS by 4c
• Soligenix, Inc. (SNGX) Tops Q2 EPS by 8c